Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Finance
ABIOMED, Inc. (ABMD) - Product Pipeline Analysis

ABIOMED, Inc. (ABMD) - Product Pipeline Analysis - new company profile report published


Print article Print article
© companiesandmarkets.com

companiesandmarkets.com
companiesandmarkets.com
2012-10-24 03:03:49 - ABIOMED, Inc. (ABMD) - Product Pipeline Analysis - a new company profile report on companiesandmarkets.com

ABIOMED, Inc. (ABMD) - Product Pipeline Analysis - ABIOMED, Inc. (Abiomed) is a medical device company that focuses on the goal of establishing heart recovery against all acute cardiac attacks. It is a provider of heart support and recovery products used by healthcare professionals. Abiomed is the only company in the world that has an exclusive labeling on ventricular assist devices for all potentially recoverable heart failure indications. The company is one of the leading providers of products in the acute heart failure market and transports more number of ventricle assist devices (VADs) than any other company in the world.

In June 2012, the company received Health Canada approval to market the Impella cVAD device, a percutaneous Impella

 

 

heart pump that provides peak flow of approximately 4 liters of blood per minute. In April 2012, the company also received CE Marking approval for Impella cVAD device.

The company operates in a single reportable segment namely, Research, Development and Sale of Medical Devices to support or replace the pumping function of the failing heart. Its products are utilized in a wide range of clinical settings by the heart surgeons for patients in profound shock and by the interventional cardiologists for patients who are in pre-shock.

This report is a source for data, analysis and actionable intelligence on the ABIOMED, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by our team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors´ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company-Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.


Author:
Mike King
e-mail
Web: www.companiesandmarkets.com
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser